These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6827176)

  • 1. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
    Peerschke EI
    Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of fibrinogens, FI and FII, to support ADP-induced platelet aggregation.
    Phillips HM; Mansouri A; Perry CA
    Thromb Haemost; 1983 Aug; 50(2):527-9. PubMed ID: 6636032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fibrinogen on the surface of ADP-stimulated platelets: comparison of human and rabbit platelets.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1988 Apr; 59(2):319-22. PubMed ID: 3388301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of platelet fibrinogen receptors by ADP and epinephrine.
    Bennett JS; Vilaire G
    J Clin Invest; 1979 Nov; 64(5):1393-401. PubMed ID: 574143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
    Rabhi-Sabile S; Pidard D
    Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
    Peerschke EI; Francis CW; Marder VJ
    Blood; 1986 Feb; 67(2):385-90. PubMed ID: 3942829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of platelet-fibrinogen interactions: modulation by divalent cations.
    Peerschke EI
    J Lab Clin Med; 1993 Jan; 121(1):135-41. PubMed ID: 8426076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
    Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
    Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of platelets with Synthocytes, a novel platelet substitute.
    Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
    Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein IIb-IIIa complexes.
    Peerschke EI
    J Lab Clin Med; 1988 Jan; 111(1):84-92. PubMed ID: 2826623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.